Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Influence of Antithrombotic Medication on the Risk of Chronic Subdural Hematoma Recurrence after Burr-Hole Surgery

  • Choi, Jongwook (Department of Neurosurgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Pyen, Jinsu (Department of Neurosurgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Cho, Sungmin (Department of Neurosurgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Kim, Jongyeon (Department of Neurosurgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Koo, Younmoo (Department of Neurosurgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine) ;
  • Whang, Kum (Department of Neurosurgery, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine)
  • Received : 2019.09.20
  • Accepted : 2019.12.31
  • Published : 2020.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Chronic subdural hematoma (CSDH) is one of the most common intracranial hemorrhages. It can be managed with a simple surgical treatment such as burr-hole trephination and drainage. However, it has a relatively high recurrence rate. The mechanisms and risk factors for the recurrence have not yet been clearly identified and studies have reported varying results. Methods : We analyzed 230 patients with CSDH who were treated with burr-hole trephination and drainage at our institution from March 2011 to March 2016. The patients were divided into recurrence and non-recurrence groups and the medical records of each group were used to analyze the risk factors associated with CSDH recurrence. Results : After burr-hole trephination and drainage, CSDH recurrence was observed in 49 (21.3%) of the 230 patients. In univariate analysis, none of the factors showed statistical significance with respect to CSDH recurrence. In multivariate analysis, preoperative antithrombotic medication was the only independent risk factor for CSDH recurrence (odds ratio, 2.407; 95% confidence interval, 1.047-5.531). Conclusion : The present study found that preoperative antithrombotic medication was independently associated with CSDH recurrence.

Keywords

References

  1. Abe Y, Maruyama K, Yokoya S, Noguchi A, Sato E, Nagane M, et al. : Outcomes of chronic subdural hematoma with preexisting comorbidities causing disturbed consciousness. J Neurosurg 126 : 1042-1046, 2017 https://doi.org/10.3171/2016.3.JNS152957
  2. Aspegren OP, Astrand R, Lundgren MI, Romner B : Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 115 : 981-984, 2013 https://doi.org/10.1016/j.clineuro.2012.10.008
  3. Borger V, Vatter H, Oszvald A, Marquardt G, Seifert V, Guresir E : Chronic subdural haematoma in elderly patients: a retrospective analysis of 322 patients between the ages of 65-94 years. Acta Neurochir (Wien) 154 : 1549-1554, 2012 https://doi.org/10.1007/s00701-012-1434-x
  4. Drapkin AJ : Chronic subdural hematoma: Pathophysiological basis for treatment. Br J Neurosurg 5 : 467-473, 1991 https://doi.org/10.3109/02688699108998475
  5. Echlin FA, Sordillo SV, Garvey TQ Jr : Acute, subacute, and chronic subdural hematoma. J Am Med Assoc 161 : 1345-1350, 1956 https://doi.org/10.1001/jama.1956.02970140001001
  6. Fleck RA, Rao LV, Rapaport SI, Varki N : Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 59 : 421-437, 1990 https://doi.org/10.1016/0049-3848(90)90148-6
  7. Fornebo I, Sjavik K, Alibeck M, Kristiansson H, Stahl F, Forander P, et al. : Role of antithrombotic therapy in the risk of hematoma recurrence and thromboembolism after chronic subdural hematoma evacuation: a population-based consecutive cohort study. Acta Neurochir (Wien) 159 : 2045-2052, 2017 https://doi.org/10.1007/s00701-017-3330-x
  8. Fujitani S, Ishikawa O, Miura K, Takeda Y, Goto H, Maeda K : Factors predicting contralateral hematoma growth after unilateral drainage of bilateral chronic subdural hematoma. J Neurosurg 126 : 755-759, 2017 https://doi.org/10.3171/2016.1.JNS152655
  9. Gernsback J, Kolcun JP, Jagid J : To drain or two drains: recurrences in chronic subdural hematomas. World Neurosurg 95 : 447-450, 2016 https://doi.org/10.1016/j.wneu.2016.08.069
  10. Jung YG, Jung NY, Kim E : Independent predictors for recurrence of chronic subdural hematoma. J Korean Neurosurg Soc 57 : 266-270, 2015 https://doi.org/10.3340/jkns.2015.57.4.266
  11. Kolias AG, Chari A, Santarius T, Hutchinson PJ : Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 10 : 570-578, 2014 https://doi.org/10.1038/nrneurol.2014.163
  12. Markwalder TM : Chronic subdural hematomas: a review. J Neurosurg 54 : 637-645, 1981 https://doi.org/10.3171/jns.1981.54.5.0637
  13. Motoie R, Karashima S, Otsuji R, Ren N, Nagaoka S, Maeda K, et al. : Recurrence in 787 patients with chronic subdural hematoma: retrospective cohort investigation of associated factors including direct oral anticoagulant use. World Neurosurg 118 : e87-e91, 2018 https://doi.org/10.1016/j.wneu.2018.06.124
  14. Nathan S, Goodarzi Z, Jette N, Gallagher C, Holroyd-Leduc J : Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma: systematic review. Neurology 88 : 1889-1893, 2017 https://doi.org/10.1212/wnl.0000000000003918
  15. Obana WG, Pitts LH : Management of head injury. Extracerebral lesions. Neurosurg Clin N Am 2 : 351-372, 1991 https://doi.org/10.1016/S1042-3680(18)30740-X
  16. Phan K, Abi-Hanna D, Kerferd J, Lu VM, Dmytriw AA, Ho YT, et al. : Resumption of antithrombotic agents in chronic subdural hematoma: a systematic review and meta-analysis. World Neurosurg 109 : e792-e799, 2018 https://doi.org/10.1016/j.wneu.2017.10.091
  17. Phuenpathom N, Choomuang M, Ratanalert S : Outcome and outcome prediction in acute subdural hematoma. Surg Neurol 40 : 22-25, 1993 https://doi.org/10.1016/0090-3019(93)90164-V
  18. Poon MTC, Al-Shahi Salman R : Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis. Neurosurg Rev 41 : 439-445, 2018 https://doi.org/10.1007/s10143-017-0860-x
  19. Poon MTC, Rea C, Kolias AG, Brennan PM; British Neurosurgical Trainee Research Collaborative (BNTRC) : Influence of antiplatelet and anticoagulant drug use on outcomes after chronic subdural hematoma drainage. J Neurotrauma, 2019 [Epub ahead of print]
  20. Rust T, Kiemer N, Erasmus A : Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy. J Clin Neurosci 13 : 823-827, 2006 https://doi.org/10.1016/j.jocn.2004.12.013
  21. Tugcu B, Tanriverdi O, Baydin S, Hergunsel B, Gunaldi O, Ofluoglu E, et al. : Can recurrence of chronic subdural hematoma be predicted? A retrospective analysis of 292 cases. J Neurol Surg A Cent Eur Neurosurg 75 : 37-41, 2014
  22. Wang H, Zhang M, Zheng H, Xia X, Luo K, Guo F, et al. : The effects of antithrombotic drugs on the recurrence and mortality in patients with chronic subdural hematoma: a meta-analysis. Medicine (Baltimore) 98 : e13972, 2019 https://doi.org/10.1097/md.0000000000013972
  23. Wang Y, Zhou J, Fan C, Wang D, Jiao F, Liu B, et al. : Influence of antithrombotic agents on the recurrence of chronic subdural hematomas and the quest about the recommencement of antithrombotic agents: a meta-analysis. J Clin Neurosci 38 : 79-83, 2017 https://doi.org/10.1016/j.jocn.2016.12.001
  24. Weigel R, Schmiedek P, Krauss JK : Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry 74 : 937-943, 2003 https://doi.org/10.1136/jnnp.74.7.937
  25. Wilson D, Charidimou A, Shakeshaft C, Ambler G, White M, Cohen H, et al. : Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type. Neurology 86 : 360-366, 2016 https://doi.org/10.1212/wnl.0000000000002310
  26. Won SY, Dubinski D, Bruder M, Cattani A, Seifert V, Konczalla J : Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome. Neurosurg Focus 43 : E12, 2017

Cited by

  1. Hematoma subdural crónico: Una patología común de manejo complejo vol.12, 2020, https://doi.org/10.25259/sni_676_2021